INT Medical Schedules 24 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express08-12

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) has announced that its board of directors will convene on 24 August 2026 in Shanghai. The session’s agenda includes:

1. Approval of the unaudited interim financial results for the six months ended 30 June 2026. 2. Deliberation on the declaration and amount of any interim dividend for shareholders.

The board is chaired by Dr. Liang Dongke and comprises nine directors: two executive directors (Dr. Liang Dongke, Mr. Lin Sen), four non-executive directors (Dr. Song Yuan, Mr. Wang Ruiqin, Ms. Chen Hongqin, Mr. Zhang Hong) and three independent non-executive directors (Mr. Jian Xigao, Mr. Hui Hung Kwan, Mr. Xu Congli).

INT Medical will publish the unaudited interim results following board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment